SYNTHESIS AND BIOLOGICAL EVALUATION OF NOVEL HETEROCYCLIC COMPOUNDS WITH ANTIMICROBIAL ACTIVITY

Authors

  • Dr. Alexey M. Voronov Department of Organic and Medicinal Chemistry, Kazan Federal University, Kazan, Russian Federation

Keywords:

heterocyclic compounds; antimicrobial activity; medicinal chemistry; synthesis; structure-activity relationship; minimum inhibitory concentration; antimicrobial resistance; lead optimization.

Abstract

The continuing expansion of antimicrobial resistance creates a strong medicinal-chemistry rationale for discovering structurally novel agents with mechanisms that differ from, or complement, established antibiotics. Heterocyclic compounds are particularly important because nitrogen-, oxygen-, and sulfur-containing rings provide tunable electronic, steric, hydrogen-bonding, and lipophilic properties that support interaction with microbial enzymes, membranes, nucleic acids, and biosynthetic pathways. This IMRAD-structured article presents a structured synthesis of international evidence on the design, synthesis, characterization, and biological evaluation of heterocyclic compounds with antimicrobial activity. Fifteen authoritative and peer-reviewed sources were selected, including the World Health Organization 2024 bacterial priority pathogens report, the CLSI M07 dilution-testing standard, and recent reviews covering triazole, imidazole, benzimidazole, thiazole, pyrazole, oxazole, oxadiazole, quinoline, and quinazoline scaffolds. The analysis indicates that antimicrobial performance depends on the integrated effect of scaffold identity, substitution pattern, ionization, lipophilicity, molecular planarity, electron-withdrawing or electron-donating groups, and the presence of hybrid pharmacophores. Reported structure-activity relationships repeatedly show that halogenated aryl groups, heteroaryl substitution, appropriate linker length, and balanced lipophilicity can improve activity, but these effects are context-dependent and do not substitute for standardized biological testing. A robust evaluation sequence should include identity and purity confirmation, MIC determination by reference dilution methods, bactericidal or fungicidal assessment where appropriate, selectivity testing, biofilm and resistance-relevant assays, and mechanistic follow-up. The article proposes an evidence-based workflow that separates exploratory screening from decision-grade antimicrobial evaluation and emphasizes reproducibility, strain selection, quality control, and avoidance of claims based only on inhibition-zone diameters. The findings support heterocyclic scaffolds as a broad and adaptable platform for antimicrobial lead discovery while highlighting the need to integrate synthetic chemistry with standardized microbiology and early developability assessment.

References

1.World Health Organization. (2024). WHO bacterial priority pathogens list, 2024: Bacterial pathogens of public health importance to guide research, development and strategies to prevent and control antimicrobial resistance. Geneva: World Health Organization. ISBN 978-92-4-009346-1.

2.Clinical and Laboratory Standards Institute. (2024). Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically (CLSI Standard M07, 12th ed.). Wayne, PA: CLSI.

3.Tian, G., Song, Q., Liu, Z., Guo, J., Cao, S., & Long, S. (2023). Recent advances in 1,2,3- and 1,2,4-triazole hybrids as antimicrobials and their SAR: A critical review. European Journal of Medicinal Chemistry, 259, 115603. https://doi.org/10.1016/j.ejmech.2023.115603

4.Strzelecka, M., & Świątek, P. (2021). 1,2,4-Triazoles as important antibacterial agents. Pharmaceuticals, 14(3), 224. https://doi.org/10.3390/ph14030224

5.Șerban, G. A., Boda, F. A., & Pop, R. R. (2021). Imidazole derivatives and their antibacterial activity - A mini-review. Mini-Reviews in Medicinal Chemistry, 21(11), 1380-1392. https://doi.org/10.2174/1389557520999201209213648

6.Tahlan, S., Kumar, S., & Narasimhan, B. (2019). Antimicrobial potential of 1H-benzo[d]imidazole scaffold: A review. BMC Chemistry, 13, 18. https://doi.org/10.1186/s13065-019-0521-y

7.Ibrahim, A. A., Said, E. G., AboulMagd, A. M., Amin, N. H., & Abdel-Rahman, H. M. (2025). Synthesis and SARs of benzimidazoles: Insights into antimicrobial innovation (2018-2024). RSC Advances, 15, 22097-22127. https://doi.org/10.1039/D5RA00819K

8.Borcea, A.-M., Ionuț, I., Crișan, O., & Oniga, O. (2021). An overview of the synthesis and antimicrobial, antiprotozoal, and antitumor activity of thiazole and bisthiazole derivatives. Molecules, 26(3), 624. https://doi.org/10.3390/molecules26030624

9.Naim, M. J., Alam, O., Nawaz, F., Alam, M. J., & Alam, P. (2016). Current status of pyrazole and its biological activities. Journal of Pharmacy & Bioallied Sciences, 8(1), 2-17. https://doi.org/10.4103/0975-7406.171694

10.Salahuddin, Mazumder, A., Yar, M. S., Mazumder, R., Chakraborthy, G. S., Ahsan, M. J., & Rahman, M. U. (2017). Updates on synthesis and biological activities of 1,3,4-oxadiazole: A review. Synthetic Communications, 47(20), 1805-1847. https://doi.org/10.1080/00397911.2017.1360911

11.Kakkar, S., & Narasimhan, B. (2019). A comprehensive review on biological activities of oxazole derivatives. BMC Chemistry, 13, 16. https://doi.org/10.1186/s13065-019-0531-9

12.Zhang, H.-Z., Zhao, Z.-L., & Zhou, C.-H. (2018). Recent advance in oxazole-based medicinal chemistry. European Journal of Medicinal Chemistry, 144, 444-492. https://doi.org/10.1016/j.ejmech.2017.12.044

13.Yadav, V. (2022). Quinoline-derivatives as privileged scaffolds for medicinal and pharmaceutical chemists: A comprehensive review. Chemical Biology & Drug Design, 100(3), 389-418. https://doi.org/10.1111/cbdd.14099

14.Halappanavar, V., Teli, S., Sannakki, H. B., & Teli, D. (2024). Quinazoline scaffold as a target for combating microbial resistance: Synthesis and antimicrobial profiling of quinazoline derivatives. Results in Chemistry, 13, 101955. https://doi.org/10.1016/j.rechem.2024.101955

15.Wang, D., & Gao, F. (2013). Quinazoline derivatives: Synthesis and bioactivities. Chemistry Central Journal, 7, 95. https://doi.org/10.1186/1752-153X-7-95

Published

2026-09-16